Treatment of chronic graft-versus-host disease in 2011
Y Inamoto, MED Flowers - Current opinion in hematology, 2011 - journals.lww.com
Y Inamoto, MED Flowers
Current opinion in hematology, 2011•journals.lww.comNo current therapies used for chronic GVHD have been approved by the US Food and Drug
Administration. Large well designed prospective studies are warranted to establish better
treatments. Targeted therapies based on the pathogenesis of chronic GVHD may lead to
better outcomes.
Administration. Large well designed prospective studies are warranted to establish better
treatments. Targeted therapies based on the pathogenesis of chronic GVHD may lead to
better outcomes.
Summary
No current therapies used for chronic GVHD have been approved by the US Food and Drug Administration. Large well designed prospective studies are warranted to establish better treatments. Targeted therapies based on the pathogenesis of chronic GVHD may lead to better outcomes.
Lippincott Williams & Wilkins